Poseida Therapeutics, Inc. (PSTX)
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.
$327.34M
Mr. Mark J. Gergen J.D.
304.00
San Diego, CA
Dec 31, 1997
-2.86
$-1.18
1.00
4.61
-19.52%
-7.41
1.67
1.59
4.54
-10.87%
-17.55%
Similar stocks (14)
Revolution Medicines, Inc.
RVMD
Cytokinetics, Incorporated
CYTK
Dyne Therapeutics, Inc.
DYN
Pliant Therapeutics, Inc.
PLRX
Stoke Therapeutics, Inc.
STOK
PepGen Inc.
PEPG
Generation Bio Co.
GBIO
Century Therapeutics, Inc.
IPSC
Lantern Pharma Inc.
LTRN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Passage Bio, Inc.
PASG
AN2 Therapeutics, Inc.
ANTX
Cue Biopharma, Inc.
CUE
IN8bio, Inc.
INAB
ETF Exposure (30)
Global X Genomics & Biotechnology ETF
GNOM
0.35%
iShares Micro-Cap ETF
IWC
0.04994%
iShares Russell 2000 Value ETF
IWN
0.01071%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 ETF
IWM
0.00702%
Schwab U.S. Small-Cap ETF
SCHA
0.0048311113%
iShares Russell 2000 Growth ETF
IWO
0.00407%
Dimensional U.S. Small Cap ETF
DFAS
0.00295607%
ProShares Ultra Russell2000
UWM
0.0027556520791609924%
ProShares UltraPro Russell2000
URTY
0.001358399438482691%
ProShares Hedge Replication ETF
HDG
0.0011578422350286535%
Dimensional US Sustainability Core 1 ETF
DFSU
8.3238e-4%
Dimensional US Core Equity Market ETF
DFAU
2.6208e-4%
Schwab U.S. Broad Market ETF
SCHB
2.390191e-4%
Dimensional U.S. Equity ETF
DFUS
1.2805e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
9.577e-5%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (14)
Revolution Medicines, Inc.
RVMD
Cytokinetics, Incorporated
CYTK
Dyne Therapeutics, Inc.
DYN
Pliant Therapeutics, Inc.
PLRX
Stoke Therapeutics, Inc.
STOK
PepGen Inc.
PEPG
Generation Bio Co.
GBIO
Century Therapeutics, Inc.
IPSC
Lantern Pharma Inc.
LTRN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Passage Bio, Inc.
PASG
AN2 Therapeutics, Inc.
ANTX
Cue Biopharma, Inc.
CUE
IN8bio, Inc.
INAB
ETF Exposure (30)
Global X Genomics & Biotechnology ETF
GNOM
0.35%
iShares Micro-Cap ETF
IWC
0.04994%
iShares Russell 2000 Value ETF
IWN
0.01071%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
iShares Russell 2000 ETF
IWM
0.00702%
Schwab U.S. Small-Cap ETF
SCHA
0.0048311113%
iShares Russell 2000 Growth ETF
IWO
0.00407%
Dimensional U.S. Small Cap ETF
DFAS
0.00295607%
ProShares Ultra Russell2000
UWM
0.0027556520791609924%
ProShares UltraPro Russell2000
URTY
0.001358399438482691%
ProShares Hedge Replication ETF
HDG
0.0011578422350286535%
Dimensional US Sustainability Core 1 ETF
DFSU
8.3238e-4%
Dimensional US Core Equity Market ETF
DFAU
2.6208e-4%
Schwab U.S. Broad Market ETF
SCHB
2.390191e-4%
Dimensional U.S. Equity ETF
DFUS
1.2805e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
9.577e-5%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%